Lai Sun Development Co Ltd (0488)
Hong Kong Stock Exchange · Hong Kong · prices in HKD · close of 27 Oct 2026
Key indicators
| Last close | HKD 0.630 |
|---|---|
| 52-week range | 0.510 – 1.080 |
| Return, 1 month / 3 months | −6.7% / −16.0% |
| Return, 1 year / 3 years | −4.5% / −36.4% |
| Trend | Below its 200-day average |
| RSI (14) | 50 |
| Volatility (1 year) | 77.4% |
| Worst drawdown (1 year) | -49.5% |
| Average daily value traded | 0.03M HKD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Lai Sun Development is a Hong Kong property and media group. It develops and invests in residential, commercial and hotel properties, chiefly in Hong Kong and mainland China, and it also holds interests in media and entertainment businesses such as television and film operations. Its property work spans development, investment and management, while its media arm produces and distributes content. The company is based in Hong Kong and serves property buyers, tenants, hotel guests and audiences across its markets.
On this site Lai Sun Development Co Ltd appears as a stock on the Hong Kong Stock Exchange (Hong Kong), code 0488, with prices in Hong Kong dollars (HKD). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Lai Sun Development Co Ltd (0488) trades on the Hong Kong Stock Exchange in Hong Kong. It last closed at HKD 0.630 on 27 October 2026.
Its price-based Market X-Ray is 39 out of 100 (a weak price profile), ranking 1,771 of 2,619 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 4.5% and over the last three months it fell 16.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Hong Kong Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 51 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -11.1% | ||
| From 52-week high | -41.1% | ||
| Momentum | 40 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -16.0% | ||
| 6-month return | -37.6% | ||
| 12-month return, skipping the last month | 2.3% | ||
| Stability (higher is calmer) | 38 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 77.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -49.5% | ||
| Liquidity | 19 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.03M HKD | ||
| Zero-volume days | 18.3% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +5.0% |
|---|---|
| 1 month | −6.7% |
| 3 months | −16.0% |
| 6 months | −37.6% |
| 1 year | −4.5% |
| 3 years | −36.4% |
| 5 years | −84.4% |
Signals
| 50-day / 200-day average | 0.660 / 0.709 |
|---|---|
| Golden / death cross (60 days) | Death, 27 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.061 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 27 Dec 2019 | HKD 0.1080 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Hong Kong Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.